Shattuck Labs logo

Shattuck LabsNASDAQ: STTK

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

09 October 2020

Next earnings report:

08 November 2024

Last dividends:

N/A

Next dividends:

N/A
$59.66 M
-92%vs. 3y high
37%vs. sector
-vs. 3y high
-vs. sector
-86%vs. 3y high
30%vs. sector
-97%vs. 3y high
80%vs. sector

Price

pre-market | Mon, 04 Nov 2024 10:03:27 GMT
$1.25$0.00(0.00%)

Dividend

No data over the past 3 years
$1.61 M$650.00 K
$1.61 M-$21.55 M

Analysts recommendations

Institutional Ownership

STTK Latest News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK
prnewswire.com02 November 2024 Sentiment: NEGATIVE

NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ: STTK).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK
accesswire.com31 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm
globenewswire.com27 October 2024 Sentiment: NEGATIVE

NEW YORK, Oct. 27, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ: STTK). Investors who purchased Shattuck securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STTK.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Shareholders to Connect
accesswire.com27 October 2024 Sentiment: NEUTRAL

NEW YORK CITY, NY / ACCESSWIRE / October 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. ("Shattuck" or "the Company") (NASDAQ:STTK). Investors who purchased Shattuck securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STTK.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK
accesswire.com27 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK
accesswire.com23 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Investors who lost money on Shattuck Labs, Inc. should contact Levi & Korsinsky about an ongoing investigation - STTK
accesswire.com23 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Shattuck Labs, Inc. ("Shattuck Labs, Inc.") (NASDAQ:STTK) concerning possible violations of federal securities laws. On October 1, 2024, Shattuck issued a press release announcing the discontinuation of its lead experimental therapy SL-172154 following disappointing early-stage data.

STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm
globenewswire.com21 October 2024 Sentiment: NEGATIVE

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ: STTK). Investors who purchased Shattuck securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STTK.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shattuck Labs, Inc. - STTK
accesswire.com21 October 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / October 21, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Stockholders to Connect
accesswire.com20 October 2024 Sentiment: NEGATIVE

NEW YORK CITY, NY / ACCESSWIRE / October 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. ("Shattuck" or "the Company") (NASDAQ:STTK). Investors who purchased Shattuck securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/STTK.

  • 1(current)
  • 2

What type of business is Shattuck Labs?

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.

What sector is Shattuck Labs in?

Shattuck Labs is in the Healthcare sector

What industry is Shattuck Labs in?

Shattuck Labs is in the Biotechnology industry

What country is Shattuck Labs from?

Shattuck Labs is headquartered in United States

When did Shattuck Labs go public?

Shattuck Labs initial public offering (IPO) was on 09 October 2020

What is Shattuck Labs website?

https://www.shattucklabs.com

Is Shattuck Labs in the S&P 500?

No, Shattuck Labs is not included in the S&P 500 index

Is Shattuck Labs in the NASDAQ 100?

No, Shattuck Labs is not included in the NASDAQ 100 index

Is Shattuck Labs in the Dow Jones?

No, Shattuck Labs is not included in the Dow Jones index

When was Shattuck Labs the previous earnings report?

No data

When does Shattuck Labs earnings report?

The next expected earnings date for Shattuck Labs is 08 November 2024